Novel Therapies for Bladder Cancer: Safety Profiles and Study Design Considerations

The Emerging Landscape of GLP-1 RA Therapies Across Conditions

Papillary muscle scarring (papSCAR) was found to be associated with increased risk of cardiac death in patients with dilated cardiomyopathy

October 14th 2025

Racial, Ethnic, and Socioeconomic Gaps Persist in US Female-Specific Cancer Burden

The founder and President of Phesi addresses the need for streamlining clinical trial data as GLP-1 RA therapies are being used to treat multiple diseases.

Listen

US map | Image Credit: Andreas Prott - stock.adobe.com

High Costs, Coverage Variability Limit Access to Incretin Mimetics for Weight Management

Persistent racial, ethnic, and socioeconomic disparities affect the incidence and mortality of major female-specific cancers in the US.

July 24th 2025

Increased Risk of Recurrence in NSCLC Found After Preoperative PTNB

This Managed Care Cast episode explores how high costs and inconsistent insurance coverage for incretin mimetics impact obesity management and patient care.

Listen

Biopsy | Image credit: arcyto - stock.adobe.com

Emerging Therapies for Managing Hidradenitis Suppurativa in Patients With Skin of Color

Individuals who had preoperative percutaneous transthoracic needle biopsy (PTNB) had an increased risk of local-regional recurrence in non–small cell lung cancer (NSCLC).

Tiffany Mayo, MD, discusses emerging therapies used to treat hidradenitis suppurativa. | Image Credit: @JPC-PROD - stock.adobe.com .jpeg

PapSCAR Prevalence May Predict Cardiac Death in Patients With Dilated Cardiomyopathy

Experts discussed safe and effective management strategies for patients with hidradenitis suppurativa at the 2025 Skin of Color Update.

Related Content

The Emerging Landscape of GLP-1 RA Therapies Across Conditions

Papillary muscle scarring (papSCAR) was found to be associated with increased risk of cardiac death in patients with dilated cardiomyopathy

October 14th 2025

Racial, Ethnic, and Socioeconomic Gaps Persist in US Female-Specific Cancer Burden

The founder and President of Phesi addresses the need for streamlining clinical trial data as GLP-1 RA therapies are being used to treat multiple diseases.

Listen

High Costs, Coverage Variability Limit Access to Incretin Mimetics for Weight Management

Persistent racial, ethnic, and socioeconomic disparities affect the incidence and mortality of major female-specific cancers in the US.

July 24th 2025

Increased Risk of Recurrence in NSCLC Found After Preoperative PTNB

This Managed Care Cast episode explores how high costs and inconsistent insurance coverage for incretin mimetics impact obesity management and patient care.

Listen

Emerging Therapies for Managing Hidradenitis Suppurativa in Patients With Skin of Color

Individuals who had preoperative percutaneous transthoracic needle biopsy (PTNB) had an increased risk of local-regional recurrence in non–small cell lung cancer (NSCLC).